Skip NavigationSkip to Content

Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia

  1. Author:
    Barth, Brian M [ORCID]
    Wang, Weiyuan
    Toran, Paul T
    Fox, Todd E
    Annageldiyev, Charyguly
    Ondrasik, Regina M
    Keasey, Nicole R
    Brown, Timothy J [ORCID]
    Devine, Viola G
    Sullivan, Emily C
    Cote, Andrea L
    Papakotsi, Vasiliki
    Tan, Su-Fern
    Shanmugavelandy, Sriram S
    Deering, Tye G
    Needle, David B [ORCID]
    Stern,Steve
    Zhu, Junjia
    Liao, Jason
    Viny, Aaron D [ORCID]
    Feith, David J
    Levine, Ross L
    Wang, Hong-Gang [ORCID]
    Loughran, Thomas P
    Sharma, Arati
    Kester, Mark
    Claxton, David F [ORCID]
  2. Author Address

    Department of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, NH., Division of Hematology and Oncology, Department of Medicine, Pennsylvania State University College of Medicine, Hershey, PA., Penn State Hershey Cancer Institute, Hershey, PA., Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, PA., Department of Pharmacology, University of Virginia School of Medicine, Charlottesville, VA., Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX., Division of Hematology and Oncology, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA., University of Virginia Cancer Center, Charlottesville, VA., Nanotechnology Characterization Laboratory, Advanced Technology Program, SAIC-Frederick, Inc., National Cancer Institute-Frederick National Laboratory for Cancer Research, Frederick, MD., Department of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey, PA., Human Oncology and Pathogenesis Program, Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Pediatric Molecular Oncology Program, Department of Pediatrics, Pennsylvania State University College of Medicine, Hershey, PA; and., nanoSTAR Institute, University of Virginia, Charlottesville, VA.,
    1. Year: 2019
    2. Date: Sep 10
  1. Journal: Blood advances
    1. 3
    2. 17
    3. Pages: 2598-2603
  2. Type of Article: Article
  3. ISSN: 2473-9529

External Sources

  1. DOI: 10.1182/bloodadvances.2018021295
  2. PMID: 31488436
  3. WOS: 000485172000007
  4. PII : bloodadvances.2018021295

Library Notes

  1. Fiscal Year: FY2019-2020
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel